Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1977 May;16(2):445–448. doi: 10.1128/iai.16.2.445-448.1977

Stable and unstable forms of human fibroblast interferon.

V G Edy, J Desmyter, A Billiau, P De Somer
PMCID: PMC420970  PMID: 863511

Abstract

There is a minor fraction of human fibroblast interferon that resembles human leukocyte interferon in being renaturable after treatment with guanidine hydrochloride. However, antigenically and in its low activity on heterologous cells, it resembles the bulk of human fibroblast interferon. Since the production of this stable interferon fraction is not greatly inhibited by glucosamine at concentrations that significantly reduce total interferon production, it is suggested that it differs from the bulk of human fibroblast interferon in the extent or nature of glycosylation.

Full text

PDF
445

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bose S., Gurari-Rotman D., Ruegg U. T., Corley L., Anfinsen C. B. Apparent dispensability of the carbohydrate moiety of human interferon for antiviral activity. J Biol Chem. 1976 Mar 25;251(6):1659–1662. [PubMed] [Google Scholar]
  2. Desmyter J., Rawls W. E., Melnick J. L. A human interferon that crosses the species line. Proc Natl Acad Sci U S A. 1968 Jan;59(1):69–76. doi: 10.1073/pnas.59.1.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Desmyter J., Stewart W. E., 2nd Molecular modification of interferon: attainment of human interferon in a conformation active on cat cells but inactive on human cells. Virology. 1976 Apr;70(2):451–458. doi: 10.1016/0042-6822(76)90286-5. [DOI] [PubMed] [Google Scholar]
  4. Duc-Goiran P., Galliot B., Chany C. Studies on virus-induced interferons produced by the human amniotic membrane and white blood cells. Arch Gesamte Virusforsch. 1971;34(3):232–243. doi: 10.1007/BF01242997. [DOI] [PubMed] [Google Scholar]
  5. Edy V. G., Billiau A., De Somer P. Human fibroblast and leukocyte interferons show different dose-response curves in assay of cell protection. J Gen Virol. 1976 May;31(2):251–255. doi: 10.1099/0022-1317-31-2-251. [DOI] [PubMed] [Google Scholar]
  6. Edy V. G., Billiau A., Joniau M., De Somer P. Stabilisation of mouse and human interferons by acid pH against inactivation due to shaking and guanidine hydrochloride. Proc Soc Exp Biol Med. 1974 May;146(1):249–253. doi: 10.3181/00379727-146-38080. [DOI] [PubMed] [Google Scholar]
  7. Gresser I., Bandu M. T., Brouty-boye D., Tovey M. Pronounced antiviral activity of human interferon on bovine and porcine cells. Nature. 1974 Oct 11;251(5475):543–545. doi: 10.1038/251543a0. [DOI] [PubMed] [Google Scholar]
  8. Havell E. A., Berman B., Ogburn C. A., Berg K., Paucker K., Vilcek J. Two antigenically distinct species of human interferon. Proc Natl Acad Sci U S A. 1975 Jun;72(6):2185–2187. doi: 10.1073/pnas.72.6.2185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Havell E. A., Vilcek J., Falcoff E., Berman B. Suppression of human interferon production by inhibitors of glycosylation. Virology. 1975 Feb;63(2):475–483. doi: 10.1016/0042-6822(75)90320-7. [DOI] [PubMed] [Google Scholar]
  10. Jankowski W. J., Davey M. W., O'Malley J. A., Sulkowski E., Carter W. A. Molecular structure of human fibroblast and leukocyte interferons: probe by lectin and hydrophobic chromatography. J Virol. 1975 Nov;16(5):1124–1130. doi: 10.1128/jvi.16.5.1124-1130.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Knight E., Jr Interferon: purification and initial characterization from human diploid cells. Proc Natl Acad Sci U S A. 1976 Feb;73(2):520–523. doi: 10.1073/pnas.73.2.520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  13. Mogensen K. E., Cantell K. Stability of human leukocyte interferon towards heat. Acta Pathol Microbiol Scand B Microbiol Immunol. 1973 Jun;81(3):382–383. doi: 10.1111/j.1699-0463.1973.tb02219.x. [DOI] [PubMed] [Google Scholar]
  14. Mogensen K. E., Pyhälä L., Cantell K. Raising antibodies to human leukocyte interferon. Acta Pathol Microbiol Scand B. 1975 Oct;83(5):443–450. doi: 10.1111/j.1699-0463.1975.tb00123.x. [DOI] [PubMed] [Google Scholar]
  15. Stewart II W. E., De Somer P., Edy V. G., Paucker K., Berg K., Ogburn C. A. Distinct molecular species of human interferons: requirements for stabilzation and reactivation of human leukocyte and fibroblast interferons. J Gen Virol. 1975 Mar;26(3):327–331. doi: 10.1099/0022-1317-26-3-327. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES